Analysts expect the New York-based company to report quarterly earnings at 68 cents per share, down from 82 cents per share ...

The Trump administration’s effort to impose new requirements on Novavax’s COVID-19 vaccine — the nation’s only traditional protein-based option for the coronavirus — is sowing uncertainty about ...